Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell Microcap Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.54 USD | -6.73% | +1.28% | -2.30% |
04-29 | UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating | MT |
03-14 | Monte Rosa Therapeutics Q4 Net Loss Narrows; Shares Decline | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.30% | 299M | |
+22.33% | 42.68B | |
-3.37% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+8.30% | 24.94B | |
-19.77% | 18.96B | |
+29.71% | 12.3B | |
-2.98% | 11.95B | |
-1.87% | 11.55B |
- Stock Market
- Equities
- GLUE Stock
- News Monte Rosa Therapeutics, Inc.
- Monte Rosa Therapeutics, Inc.(NasdaqGS: GLUE) added to Russell Microcap Index